Yanlian Li

682 total citations
22 papers, 543 citations indexed

About

Yanlian Li is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Yanlian Li has authored 22 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 5 papers in Hematology and 2 papers in Organic Chemistry. Recurrent topics in Yanlian Li's work include Protein Degradation and Inhibitors (9 papers), Multiple Myeloma Research and Treatments (5 papers) and Ubiquitin and proteasome pathways (5 papers). Yanlian Li is often cited by papers focused on Protein Degradation and Inhibitors (9 papers), Multiple Myeloma Research and Treatments (5 papers) and Ubiquitin and proteasome pathways (5 papers). Yanlian Li collaborates with scholars based in China and United States. Yanlian Li's co-authors include Bing Xiong, Jingkang Shen, Danyan Cao, Shan Liu, Haipeng Liu, Jun Li, Xin Wang, Jian Li, Ze‐Hong Miao and Ying-Qing Wang and has published in prestigious journals such as Journal of Medicinal Chemistry, Frontiers in Immunology and Molecules.

In The Last Decade

Yanlian Li

20 papers receiving 534 citations

Peers

Yanlian Li

HEMAT

IMMUN

CTM

Neeraj K. Mishra United States

Ganapathy N. Sarma United States

Christoph Arkona Germany

Mariola Andrzejewska Poland

Amy Bunker United States

Shalini Singh India

Letian Kuai China

Kenneth J. Addess United States

Pierrick Craveur France

William M. Hewitt United States

Neeraj K. Mishra United States

Yanlian Li

390 ×1.0

85 ×0.6

HEMAT

7 ×0.1

IMMUN

27 ×0.3

CTM

66 ×0.9

Citations per year, relative to Yanlian Li Yanlian Li (= 1×) peers Neeraj K. Mishra

Countries citing papers authored by Yanlian Li

Since Specialization

Citations

This map shows the geographic impact of Yanlian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanlian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanlian Li more than expected).

Fields of papers citing papers by Yanlian Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanlian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanlian Li. The network helps show where Yanlian Li may publish in the future.

Co-authorship network of co-authors of Yanlian Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yanlian Li. A scholar is included among the top collaborators of Yanlian Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanlian Li. Yanlian Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Yueyue, Haiyang Zhong, Yanlian Li, et al.. (2025). Design of Selective BRD4 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease. Journal of Medicinal Chemistry. 68(5). 5257–5274. 2 indexed citations

Gong, Chaoju, Xiao Yang, Jie Li, et al.. (2024). The Consistency of Anti-Toxocara IgG Between the Aqueous Humor and Vitreous of Patients With Clinically Suspected Ocular Toxocariasis. American Journal of Ophthalmology. 267. 90–99. 2 indexed citations

Mou, Jie, Huijie Zhang, Yanlian Li, et al.. (2024). Structure-Based Rational Design and Evaluation of BET-Aurora Kinase Dual-Inhibitors for Treatment of Cancers. Journal of Medicinal Chemistry. 68(2). 1344–1364. 5 indexed citations

Li, Na, Hong Yang, Ke Liu, et al.. (2022). Structure-Based Discovery of a Series of NSD2-PWWP1 Inhibitors. Journal of Medicinal Chemistry. 65(13). 9459–9477. 20 indexed citations

Zhang, Zhuqing, Xiaowei Xu, Danyan Cao, et al.. (2021). Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy. Journal of Medicinal Chemistry. 64(22). 16650–16674. 25 indexed citations

Liu, Shan, et al.. (2020). Hemocyte-Mediated Phagocytosis in Crustaceans. Frontiers in Immunology. 11. 268–268. 107 indexed citations

Hu, Jianping, Changqing Tian, Yanlian Li, et al.. (2019). Structure-Based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors. Journal of Medicinal Chemistry. 62(18). 8642–8663. 31 indexed citations

Zhang, Zhuqing, Hong Yang, Danyan Cao, et al.. (2019). Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid Leukemia. Journal of Medicinal Chemistry. 62(11). 5414–5433. 21 indexed citations

Chen, Danqi, Yuehong Chen, Fulin Lian, et al.. (2018). Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction. European Journal of Medicinal Chemistry. 163. 597–609. 22 indexed citations

10.

Hu, Jianping, Ying-Qing Wang, Yanlian Li, et al.. (2018). Structure-based optimization of a series of selective BET inhibitors containing aniline or indoline groups. European Journal of Medicinal Chemistry. 150. 156–175. 19 indexed citations

11.

Hu, Jianping, Ying-Qing Wang, Yanlian Li, et al.. (2017). Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor. European Journal of Medicinal Chemistry. 137. 176–195. 30 indexed citations

12.

Wang, Ying-Qing, Danyan Cao, Tiantian Chen, et al.. (2015). Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: 2. Structure-Based Optimization. Journal of Medicinal Chemistry. 58(3). 1281–1297. 44 indexed citations

13.

Ren, Jing, Jian Li, Yueqin Wang, et al.. (2014). Identification of a new series of potent diphenol HSP90 inhibitors by fragment merging and structure-based optimization. Bioorganic & Medicinal Chemistry Letters. 24(11). 2525–2529. 17 indexed citations

14.

Cao, Danyan, Tiantian Chen, Ying-Qing Wang, et al.. (2013). Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain. Journal of Medicinal Chemistry. 56(10). 3833–3851. 97 indexed citations

15.

Zheng, Mingyue, Yanlian Li, Bing Xiong, Hualiang Jiang, & Jingkang Shen. (2012). Water PMF for predicting the properties of water molecules in protein binding site. Journal of Computational Chemistry. 34(7). 583–592. 27 indexed citations

16.

Xue, Mengzhu, Mingbo Su, Dingyu Hu, et al.. (2012). CCLab—a multi-objective genetic algorithm based combinatorial library design software and an application for histone deacetylase inhibitor design. Bioorganic & Medicinal Chemistry Letters. 22(14). 4540–4545. 8 indexed citations

17.

Xia, Guangxin, Mengzhu Xue, Lin Liu, et al.. (2011). Potent and novel 11β-HSD1 inhibitors identified from shape and docking based virtual screening. Bioorganic & Medicinal Chemistry Letters. 21(19). 5739–5744. 14 indexed citations

18.

Xue, Mengzhu, Mingyue Zheng, Bing Xiong, et al.. (2010). Knowledge-Based Scoring Functions in Drug Design. 1. Developing a Target-Specific Method for Kinase−Ligand Interactions. Journal of Chemical Information and Modeling. 50(8). 1378–1386. 28 indexed citations

19.

Li, Yanlian. (2008). Medicinal Plant Resources of Viola and Its Utiliazation in Shandong Province. Northern Horticulture. 1 indexed citations

20.

Li, Yanlian. (2005). Studies on the flora of climbing plants in Ma-toushan Nature Reserve in Jiangxi Province. Guihaia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact